Ownership history in Prosight Management, LP · 11 quarters on record
This page tracks every 13F SEC filing in which Prosight Management, LP reported a position in IMMUNOVANT INC (IMVT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 243,404 | -455,068 | -65.2% | 1.28% | $6.2M | $25.42 |
| 2025 Q3 | ADDED | 698,472 | +219,072 | +45.7% | 2.63% | $11.3M | $16.12 |
| 2025 Q2 | ADDED | 479,400 | +119,400 | +33.2% | 1.87% | $7.7M | $16.00 |
| 2025 Q1 | ADDED | 360,000 | +54,477 | +17.8% | 2.02% | $6.2M | $17.09 |
| 2024 Q4 | REDUCED | 305,523 | -64,477 | -17.4% | 2.09% | $7.6M | $24.77 |
| 2024 Q3 | ADDED | 370,000 | +45,000 | +13.8% | 2.60% | $10.5M | $28.51 |
| 2024 Q2 | ADDED | 325,000 | +130,000 | +66.7% | 2.56% | $8.6M | $26.40 |
| 2024 Q1 | ADDED | 195,000 | +99,500 | +104.2% | 1.75% | $6.3M | $32.31 |
| 2020 Q2 | REDUCED | 95,500 | -25,929 | -21.4% | 1.00% | $2.3M | $24.35 |
| 2020 Q1 | REDUCED | 121,429 | -103,273 | -46.0% | 0.88% | $1.9M | $15.56 |
As of 2025 Q4 — sorted by position size